Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SWTX | SpringWorks Therapeutics, Inc. | Head of Research & Development | $2.06M | Jul 18, 2022 | ||
SYBX | SYNLOGIC, INC. | Director | Jun 22, 2023 | |||
TSBX | Turnstone Biologics Corp. | Interim Chief Medical Officer, Director | Oct 16, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|